hepatocellular carcinoma |
22 |
extracellular vesicles |
17 |
intercellular communication |
13 |
nidogen 1 |
11 |
preāmetastatic niche |
11 |
tumor necrosis factor receptor 1 |
11 |
liver cancer |
10 |
neutralizing antibody |
10 |
proteomics |
10 |
tumor microenvironment |
10 |
therapeutics |
9 |
galectin-1 |
8 |
glycolysis |
8 |
mir-22 |
8 |
otx008 |
8 |
rab20 gtpase |
8 |
triosephosphate isomerase 1 |
8 |
metastasis |
7 |
small extracellular vesicles |
7 |
feedback signaling |
6 |
nuclear factor kappa b |
6 |
nuclear met |
6 |
transforming growth factor beta-activated kinase 1 |
6 |
von willebrand factor |
6 |
biomarker |
5 |
microrna |
5 |
protein stability |
5 |
clathrin light chain a |
4 |
complement factor h |
4 |
complement-mediated cytotoxicity |
4 |
hepatocellularcarcinoma |
4 |
premetastatic niche |
4 |
vascular permeability |
4 |
arp2/3 |
3 |
arpc2 |
3 |
biomarkers |
3 |
cancer metastasis |
3 |
cell motility |
3 |
crispr/cas9 |
3 |
knockout |
3 |
tumor oncology |
3 |
liver - cancer - molecular aspects |
2 |
exosome |
1 |
tumor formation and progression |
1 |